Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Current Assets
QFRTCA385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
418,251.00
Year-over-Year Change
11.77%
Date Range
10/1/2000 - 4/1/2025
Summary
This economic indicator tracks the total current assets of U.S. pharmaceutical and medicine corporations on a quarterly basis. It provides crucial insights into the financial health and liquidity of a critical sector in the American economy.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The trend represents the short-term financial resources available to pharmaceutical companies, including cash, marketable securities, and inventory. Economists use this metric to assess sector-wide financial stability, investment potential, and overall economic performance in healthcare-related industries.
Methodology
Data is collected through comprehensive quarterly financial reports submitted by pharmaceutical corporations to regulatory agencies, then aggregated and standardized by the U.S. Federal Reserve.
Historical Context
This indicator is used by investors, policymakers, and financial analysts to evaluate the economic resilience and investment potential of the pharmaceutical sector.
Key Facts
- Reflects short-term financial resources of pharmaceutical corporations
- Provides quarterly snapshot of sector financial performance
- Includes cash, inventory, and marketable securities
FAQs
Q: What does 'total current assets' mean?
A: Total current assets represent all short-term financial resources a company can convert to cash within one year, including cash, inventory, and marketable securities.
Q: Why are pharmaceutical current assets important?
A: These assets indicate a company's financial flexibility, ability to fund research, and potential for investment in new drug development.
Q: How often is this data updated?
A: The data is typically updated quarterly by the U.S. Federal Reserve, providing a consistent view of sector financial performance.
Q: How do investors use this information?
A: Investors analyze current assets to assess a company's financial health, liquidity, and potential for future growth and innovation.
Q: What are the limitations of this data?
A: The data provides a snapshot of financial resources and does not directly indicate future performance or profitability of individual companies.
Related News
Gen Z In the U.S. Shifts From Spending To Saving Habits
How Gen Z's Shift from Spending to Saving is Impacting the US Economy Recent trends indicate a significant shift in the spending habits of Gen Z, w...
U.S. Treasury Yields Decline After Inflation Data Meet Expectations
US Treasury Yields Drop as Inflation Data Meets Expectations US Treasury yields have seen a noticeable decline recently, as the latest inflation da...
S&P 500 Rises With Optimistic U.S. Inflation Report
S&P 500 Soars: Positive U.S. Inflation Developments The S&P 500, a primary stock index that tracks the performance of 500 major U.S. companies, has...
U.S. Stock Market Rises Amid PCE Inflation Report Analysis
U.S. Stock Market Climbs Amidst Insights from PCE Inflation Report Investors in the U.S. stock market are focusing on the most recent PCE Inflation...
U.S. GDP Growth to Slow Due to Tariffs and Immigration Policies
How Tariffs and Immigration Policies Influence U.S. GDP Growth in 2025 The U.S. GDP is a fundamental gauge of the country's economic health. Recent...
U.S. Stock Market Futures Rise On Inflation and Tariff News
US Stock Market Futures Rise Amid Inflation Data and Tariff News US stock market futures are on the rise, driven by significant updates in inflatio...
Related Trends
Quarterly Financial Report: U.S. Corporations: All Other Retail Trade: Stockholders' Equity
QFR327OTRUSNO
Quarterly Financial Report: U.S. Corporations: Motion Picture and Sound Recording Industries: Income (Loss) from Operations
QFR104512USNO
Quarterly Financial Report: U.S. Corporations: Basic Chemicals, Resins, and Synthetics: Trade Accounts and Trade Notes Payable
QFR306375USNO
Quarterly Financial Report: U.S. Corporations: Food: All Other Noncurrent Assets
QFRD222311USNO
Quarterly Financial Report: U.S. Corporations: Textile Mills and Textile Product Mills: Total Liabilities
QFRTL313USNO
Quarterly Financial Report: U.S. Corporations: Plastics and Rubber Products: Retained Earnings
QFR322326USNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Current Assets [QFRTCA385USNO], retrieved from FRED.
Last Checked: 8/1/2025